公开(公告)号：EP3062829A4

公开(公告)日：2017-07-05

申请号：EP14858437

申请日：2014-10-31

申请人： NOVABAY PHARMACEUTICALS INC

发明人： FRANCAVILLA CHARLES ,  STROMAN DAVID W

IPC分类号： A61L12/00 ,  G02C13/00

CPC分类号： G02C13/008

公开(公告)号：EP2341886B1

公开(公告)日：2015-08-26

申请号：EP09825526.8

申请日：2009-11-06

申请人： NovaBay Pharmaceuticals, Inc.

发明人： JAIN, Rakesh, K. ,  LOW, Eddy ,  FRANCAVILLA, Charles ,  SHIAU, Timothy, P. ,  NAIR, Satheesh, K.

IPC分类号： A61K8/00 ,  C07C229/12 ,  C07C229/34 ,  C07C271/54 ,  A61K31/14

CPC分类号： C07C229/12 ,  A61K31/14 ,  C07C229/34 ,  C07C271/54

公开(公告)号：EP2341886A4

公开(公告)日：2012-08-01

申请号：EP09825526

申请日：2009-11-06

申请人： NOVABAY PHARMACEUTICALS INC

发明人： JAIN RAKESH K ,  LOW EDDY ,  FRANCAVILLA CHARLES ,  SHIAU TIMOTHY P ,  NAIR SATHEESH K

IPC分类号： A61K8/00 ,  A61K31/14 ,  C07C229/12 ,  C07C229/34 ,  C07C271/54

CPC分类号： C07C229/12 ,  A61K31/14 ,  C07C229/34 ,  C07C271/54

公开(公告)号：EP2341777A1

公开(公告)日：2011-07-13

申请号：EP09825372.7

申请日：2009-11-04

申请人： NovaBay Pharmaceuticals, Inc.

发明人： JAIN, Rakesh, K. ,  LOW, Eddy ,  FRANCAVILLA, Charles ,  SHIAU, Timothy P. ,  KIM, Bum ,  NAIR, Satheesh, K.

IPC分类号： A01N43/76 ,  A61K31/42 ,  A61K31/415

CPC分类号： A01N43/76 ,  A01N35/02 ,  A01N43/90 ,  A01N59/00 ,  A61K31/415 ,  A61K31/42 ,  C07D233/80 ,  C07D233/82 ,  C07D263/20 ,  C07D263/26 ,  C07D471/10 ,  C07D498/10

摘要： The present application relates to
N -chlorinated oxazolidinone, hydantoin and imidazolidinone compounds of Formula (I): or pharmaceutically acceptable salts thereof, and associated compositions and methods of use as antimicrobial agents.

公开(公告)号：EP2265267A1

公开(公告)日：2010-12-29

申请号：EP09729990.3

申请日：2009-04-10

申请人： NovaBay Pharmaceuticals, Inc.

发明人： GOTTARDI, Waldemar ,  NAGL, Markus ,  NAJAFI, Ramin ,  WANG, Lu ,  JAIN, Rakesh, K. ,  SHIAU, Timothy, P. ,  LOW, Eddy ,  FRANCAVILLA, Charles

IPC分类号： A61K31/14 ,  A61K31/185 ,  A61K31/198 ,  A61K31/205 ,  A61K31/452 ,  A61K31/662 ,  A61K31/69 ,  A61K33/02 ,  A61P11/00 ,  A61P31/00

CPC分类号： A61K31/185 ,  A61K31/14 ,  A61K31/198 ,  A61K31/205 ,  A61K31/452 ,  A61K31/662 ,  A61K31/69 ,  A61K33/02

摘要： Disclosed herein are methods and compositions for the treatment or prophylaxis, in a mammal, of bronchopulmonary infections, obstructive pulmonary disease, cystic fibrosis, and ventilator-associated infections. The methods and compositions include a therapeutically effective amount of one or more N-halogenated or N,N-dihalogenated amines, and their analogues, derivatives, or pharmaceutically acceptable salts and esters.

公开(公告)号：EP1948154A1

公开(公告)日：2008-07-30

申请号：EP06825586.8

申请日：2006-10-05

申请人： Novabay Pharmaceuticals, Inc.

发明人： NAJAFI, Ramin ,  BASSIRI, Mansour ,  WANG, Lu ,  KHOSROVI, Behzad

IPC分类号： A61K31/198 ,  A61K31/185 ,  A61K33/00 ,  A61K33/20 ,  A61K47/00 ,  A61K47/02 ,  A61L29/16 ,  A61M25/00 ,  A61M1/00 ,  A61M1/28 ,  A61M1/14 ,  A61M31/00 ,  A61M16/00 ,  A61M16/04 ,  A61P13/02

CPC分类号： A61K9/0024 ,  A61K31/185 ,  A61K31/195 ,  A61K31/198 ,  A61K33/00 ,  A61K33/14 ,  A61K33/20 ,  A61L29/16 ,  A61L2300/106 ,  A61L2300/214 ,  A61L2300/404 ,  A61M1/285 ,  A61M16/04 ,  A61M2202/203 ,  A61K2300/00

摘要： Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.